Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Belinda N. Rivera‐Lebron"'
Autor:
Jacob DeBerry, Parth Rali, Michael McDaniel, Christopher Kabrhel, Rachel Rosovsky, Roman Melamed, Oren Friedman, Jean M. Elwing, Vijay Balasubramanian, Sandeep Sahay, Eduardo Bossone, Mary Jo S. Farmer, Andrew J. P. Klein, Megan E. Hamm, Charles B. Ross, Belinda N. Rivera-Lebron
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundInterhospital transfer (IHT) of patients with acute life-threatening pulmonary embolism (PE) is necessary to facilitate specialized care and access to advanced therapies. Our goal was to understand what barriers and facilitators may exist d
Externí odkaz:
https://doaj.org/article/75aab6db92144cddab7123221e778e61
Autor:
Stephen D’Auria, Ahmet Sezer, Floyd Thoma, Michael Sharbaugh, Jeffrey McKibben, Robert Maholic, Efthymios D. Avgerinos, Belinda N. Rivera-Lebron, Catalin Toma
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Background Catheter-directed thrombolysis (CDL) is increasingly being used for the treatment of submassive and massive pulmonary embolism. Although this therapy has been shown to be effective at reducing right ventricle strain, the impact on clinical
Externí odkaz:
https://doaj.org/article/71428da35c274b778445f169538c35a6
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 11 (2017)
Pulmonary arterial hypertension (PAH) is a progressive disease defined by an elevation in pulmonary arterial pressure that can lead to right heart failure and death. Ambrisentan is a selective endothelin receptor antagonist approved for the treatment
Externí odkaz:
https://doaj.org/article/7918a69485554b42b927462bb488443f
Autor:
Mateo Porres-Aguilar, Rachel P. Rosovsky, David Jiménez, Debabrata Mukherjee, Belinda N. Rivera-Lebron, Scott Kaatz, Javier E. Anaya-Ayala, Carlos Jerjes-Sánchez
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1390-1392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de47b36e0769bc22a746568de5f003b8
https://doi.org/10.1016/j.jtha.2023.02.001
https://doi.org/10.1016/j.jtha.2023.02.001
Autor:
Mateo Porres‐Aguilar, Rachel P. Rosovsky, Belinda N. Rivera‐Lebron, Scott Kaatz, Debabrata Mukherjee, Javier E. Anaya‐Ayala, David Jimenez, Carlos Jerjes‐Sánchez
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2457-2464
Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary, multispecialty team of experts in the care of highly complex symptomatic acute pulmonary embolism (PE), with a centralized unique activation process, providing rapid multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9447db80caf091cc5597c2a46f072e7a
https://doi.org/10.1111/jth.15832
https://doi.org/10.1111/jth.15832
Autor:
Efthymios D. Avgerinos, Wissam Jaber, Joan Lacomis, Kyle Markel, Michael McDaniel, Belinda N. Rivera-Lebron, Charles B. Ross, Jacob Sechrist, Catalin Toma, Rabih Chaer, M. Gladwin, P. Lamberty, C. Kabrhel, A.J. Klein, M.S. Makaroun, C.E. Miller, A. Mohapatra, I. Ocak, H. Phelos, R. Sachdeva, Georges Al-Khoury, Michael Madigan, Nathan Liang, Larry Fish, Heather Phelos, Julianna Sheline, Judith Brimmeier
Publikováno v:
JACC: Cardiovascular Interventions. 14:1364-1373
Objectives The aim of this trial was to determine whether ultrasound-assisted thrombolysis (USAT) is superior to standard catheter-directed thrombolysis (SCDT) in pulmonary arterial thrombus reduction for patients with submassive pulmonary embolism (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff5efbe51f3d3c7ba3aa212de6ad37b3
https://doi.org/10.1016/j.jcin.2021.04.049
https://doi.org/10.1016/j.jcin.2021.04.049
Autor:
Efthymios D, Avgerinos, Wissam, Jaber, Joan, Lacomis, Kyle, Markel, Michael, McDaniel, Belinda N, Rivera-Lebron, Charles B, Ross, Jacob, Sechrist, Catalin, Toma, Rabih, Chaer, Judith, Brimmeier
Publikováno v:
JACC Cardiovasc Interv
OBJECTIVES: The aim of this trial was to determine whether ultrasound-assisted thrombolysis (USAT) is superior to standard catheter-directed thrombolysis (SCDT) in pulmonary arterial thrombus reduction for patients with submassive pulmonary embolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8b60df515212a04351b715e829cd5255
https://europepmc.org/articles/PMC9057455/
https://europepmc.org/articles/PMC9057455/
Autor:
Mateo, Porres-Aguilar, Marius M, Hoeper, Belinda N, Rivera-Lebron, Gustavo A, Heresi, Debabrata, Mukherjee, Victor F, Tapson
Publikováno v:
Journal of thrombosis and thrombolysis. 52(3)
Chronic thromboembolic pulmonary hypertension (CTEPH) represents the later stage consequence of at least one or more unresolved episodes of acute pulmonary embolism; thus, indefinite anticoagulation is strongly recommended by current practice guideli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fae25578247ac033ca6b0ad794212e87
https://pubmed.ncbi.nlm.nih.gov/33835334
https://pubmed.ncbi.nlm.nih.gov/33835334
Publikováno v:
Chest. 159(1)
Pulmonary embolism (PE) is a major source of morbidity and mortality. The presentation of acute PE varies, ranging from few or no symptoms to sudden death. Patient outcome depends on how well the right ventricle can sustain the increased afterload ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08d1befa06af76309345d16839abbde8
https://pubmed.ncbi.nlm.nih.gov/32758561
https://pubmed.ncbi.nlm.nih.gov/32758561
Publikováno v:
Clinics in chest medicine. 39(3)
Venous thromboembolism (VTE) is a common cause of morbidity and mortality. Presence of preexisting conditions, such as cardiopulmonary diseases, cirrhosis, renal dysfunction, and asplenia, commonly occurs in VTE patients. Moreover, these conditions o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4e367dda4cb80664cfb0b45e4a16c23
https://pubmed.ncbi.nlm.nih.gov/30122176
https://pubmed.ncbi.nlm.nih.gov/30122176